NEW YORK, Aug 14 – Eksigent Technologies has announced that it has licensed Sandia National Laboratories’ microfluidics technology.

Eksigent and Sandia, both of Livermore, Calif., did not disclose the terms of the deal or describe the specific technologies involved. Sandia licensed Eksigent the technology through its tech transfer program.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.